Consolidated Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net Revenues:
Services	$ 3,167,411	$ 3,287,272	$ 9,711,137	$ 9,388,267
Product sales	1,123,607	1,195,700	3,254,655	3,707,840
Total revenues	4,291,018	4,482,972	12,965,792	13,096,107
Cost of Services and Sales:
Cost of services	1,396,400	1,299,030	4,133,334	3,814,933
Cost of sales	412,876	462,048	1,210,069	1,259,404
Total cost of services and sales	1,809,276	1,761,078	5,343,403	5,074,337
Gross Margin	2,481,742	2,721,894	7,622,389	8,021,770
Operating Expenses:
Selling, general and administrative	3,517,041	3,316,295	10,989,745	10,039,289
Bad debt expense	371,552	387,388	1,024,207	628,215
Impairment of goodwill			3,041,000
Depreciation and amortization	313,669	279,463	920,905	836,936
Total operating expenses	4,202,262	3,983,146	15,975,857	11,504,440
Other (Expense):
Interest expense, net	(271,363)	(300,791)	(843,562)	(975,735)
Other expense		(3,000)		(12,234)
Net other (expense)	(271,363)	(303,791)	(843,562)	(987,969)
Income (loss) from continuing operations, before taxes	(1,991,883)	(1,565,043)	(9,197,030)	(4,470,639)
(Provision) benefit for income taxes		(3,498)		(10,494)
Income (loss) from continuing operations, net of taxes	(1,991,883)	(1,568,541)	(9,197,030)	(4,481,133)
Income (loss) from discontinued operations, net of taxes	(283,961)	(14,896)	(364,172)	376,478
Net income (loss)	(2,275,844)	(1,583,437)	(9,561,202)	(4,104,655)
Less: Net income (loss) attributable to noncontrolling interests	(45,269)	(27,544)	(138,510)	(130,626)
Net income (loss) attributable to Graymark Healthcare	$ (2,230,575)	$ (1,555,893)	$ (9,422,692)	$ (3,974,029)
Earnings per common share (basic and diluted):
Net income (loss) from continuing operations	$ (0.13)	$ (0.10)	$ (0.60)	$ (0.42)
Income (loss) from discontinued operations	$ (0.02)		$ (0.02)	$ 0.04
Net income (loss) per share	$ (0.15)	$ (0.10)	$ (0.62)	$ (0.38)
Weighted average number of common shares outstanding	15,176,938	14,885,911	15,121,218	10,332,069
Weighted average number of diluted shares outstanding	15,176,938	14,885,911	15,121,218	10,332,069